Ticker
ADCTCompany Name
ADC THERAPEUTICS SASector
HealthcareIndustry
BiotechnologyExchange
NYSEDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 321.56M | $ 264.56M | $ 57M | $ 0 |
3/31/2025 | $ 272.54M | $ 194.7M | $ 77.84M | $ 0 |
12/31/2024 | $ 321.98M | $ 250.87M | $ 71.11M | $ 0 |
9/30/2024 | $ 349.08M | $ 274.27M | $ 74.81M | $ 0 |
6/30/2024 | $ 371.78M | $ 300.12M | $ 71.66M | $ 0 |
3/31/2024 | $ 307.97M | $ 234.28M | $ 73.68M | $ 0 |
12/31/2023 | $ 354.78M | $ 278.6M | $ 76.18M | $ 0 |
9/30/2023 | $ 466.9M | $ 310.41M | $ 144.13M | $ 12.36M |
6/30/2023 | $ 507.3M | $ 347.51M | $ 146.26M | $ 13.54M |
3/31/2023 | $ 467.67M | $ 310.55M | $ 143.54M | $ 13.59M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for ADC THERAPEUTICS SA is calculated as follows: Assets [ $ 521.53M ] - Intangibles [ $ 9.81M ] - CashnEq [ $ 494.42M ]
(=) Core Assets [ $ 17.3M ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2022
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.36B |
average | $ 798.36M |
median | $ 287.51M |
std | $ 1.05B |